We are live on
!
Find out more
CCM
Compass Capital Management Portfolio holdings
AUM
$1.66B
1-Year Est. Return
7.83%
This Fund
S&P 500
This Quarter
Est. Return
+4.89%
1 Year Est. Return
+7.83%
3 Year Est. Return
+47.1%
5 Year Est. Return
+55.91%
10 Year Est. Return
+237.22%
AUM
$444M
AUM Growth
+$33.4M
(+8.1%)
Cap. Flow
+$8.14M
Cap. Flow
% of AUM
1.83%
Top 10 Holdings %
Top 10 Hldgs %
33.84%
Holding
59
New
8
Increased
29
Reduced
15
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$860K |
| 2 |
Pfizer
PFE
|
+$840K |
| 3 |
Sherwin-Williams
SHW
|
+$785K |
| 4 |
Accenture
ACN
|
+$701K |
| 5 |
Microsoft
MSFT
|
+$624K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson Controls International
JCI
|
+$675K |
| 2 |
NVO
Novo Nordisk
NVO
|
+$343K |
| 3 |
Northrop Grumman
NOC
|
+$292K |
| 4 |
Expeditors International
EXPD
|
+$250K |
| 5 |
Merck
MRK
|
+$215K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.11% |
| 2 | Industrials | 17.02% |
| 3 | Technology | 15.59% |
| 4 | Consumer Staples | 9.84% |
| 5 | Materials | 6.95% |
Similar funds
BFPW
PP
ACM
RIA
GACM
GWM
CPO
Compass Capital Management's Q3 2013 Portfolio in Review
As of Q3 2013, Compass Capital Management held 59 positions worth $444M, up 8.1% from $411M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Compass Capital Management's Q3 2013 filing shows 8 new, 29 increased, 15 reduced and 4 closed positions. Its largest new stake was Pfizer: 30,856 shares worth $841K. The largest sale was Johnson Controls International, an estimated $675K.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Industrials and Technology.
- Compass Capital Management's largest Q3 2013 buy was Pfizer: 30,856 shares worth $841K.
- Compass Capital Management added most to Walmart Inc in Q3 2013, an estimated $860K increase.
- Compass Capital Management's biggest Q3 2013 reduction was Johnson Controls International, cutting an estimated $675K.
- Compass Capital Management fully exited Novo Nordisk in Q3 2013, selling an estimated $343K.
- Compass Capital Management's ten largest holdings make up 34% of its $444M portfolio in Q3 2013.
- Compass Capital Management opened 8 new positions and closed 4 in Q3 2013.
- Compass Capital Management's portfolio value rose 8.1% quarter-over-quarter to $444M.
Based on Compass Capital Management's 13F filing for Q3 2013, filed 24 Oct 2013.